AI Verdict
GDRX has stronger fundamentals based on our AI analysis.
GDTC vs GDRX Fundamental Comparison
| Metric | GDTC | GDRX |
|---|---|---|
| Revenue | N/A | $796.9M |
| Net Income | N/A | $30.4M |
| Net Margin | N/A | 3.8% |
| ROE | N/A | 4.9% |
| ROA | N/A | 2.2% |
| Current Ratio | N/A | 2.61x |
| Debt/Equity | N/A | 0.80x |
| EPS | N/A | $0.09 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
GDTC vs GDRX: Frequently Asked Questions
Is GDTC or GDRX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), GDRX has stronger fundamentals. GDTC is rated HOLD (5% confidence) while GDRX is rated BUY (72% confidence). This is not investment advice.
How does GDTC compare to GDRX fundamentally?
CytoMed Therapeutics Ltd has ROE of N/A vs GoodRx Holdings, Inc.'s 4.9%. Net margins are N/A vs 3.8% respectively.
Which stock pays higher dividends, GDTC or GDRX?
GDTC has a dividend yield of N/A or no dividend while GDRX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in GDTC or GDRX for long term?
For long-term investing, consider that GDTC has HOLD rating with 5% confidence, while GDRX has BUY rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about GDTC vs GDRX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For GDTC vs GDRX, the AI consensus favors GDRX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.